Predictive factors for pneumonia in adults infected with the new pandemic a (H1H1) influenza virus;Factores predictivos de neumonía en pacientes infectados por el nuevo virus de la gripe a (H1N1) pandémica

Revista Espanola de Quimioterapia

Volumn 24, Issue 4, 2011, Pages 204-208

  Chippirraz, Elisabet Lerma ^a   Sorlí, Lluisa ^a   Montero, Milagro ^a   Mas, Virgina ^a   Granados, Eduardo López ^a   Vilaplana, Carles ^b   Álvarez Lerma, Francisco ^a   Knobel, Hernando ^a   Horcajada, Juan Pablo ^a  

^a HOSPITAL DEL MAR   (Spain)

^b Laboratori de Referencia de Catalunya   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G2;

2009 H1N1 INFLUENZA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HOSPITAL ADMISSION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTENSIVE CARE; OBESITY; PNEUMONIA; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TIME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD CHEMICAL ANALYSIS; BLOOD GAS ANALYSIS; C-REACTIVE PROTEIN; COHORT STUDIES; DELAYED DIAGNOSIS; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OBESITY; PNEUMONIA, VIRAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84856057298     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lindsey R. Baden, Drazen JM, Kritek PA, Curfman GD, Morrissey S, Campion EW. H1N1 Influenza A disease-Information for Health Professionals. N Engl J Med 2009; 360; 2666-7.
2. Dawood FS, Jain S, Firelli L, Shaw MW, Lindstrom S, Garten RJ. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans. N Engl J Med 2009 360; 2605-15.
3. Gómez-Gómez A, Martínez-Martínez R, Gotway MB. Organizing pneumonia associated with swine-origin influenza A H1N1 2009 viral infection. AJR Am J Roentgenol 2011; 196: 103-4.
4. Navarro-Marí JM, Mayoral JM, Pérez-Ruiz M, Rodríguez-Baño J, Carratalá J, Gallardo-García V. Infección en humanos por virus de la gripe A(H1N1): revisión al 30 de octubre de 2009. Enferm Infecc Microbiol Clin 2010; 28: 446-52.
5. Viasus D, Paño-Pardo JR, Padrón J, Campins A, López-Medrano F, Fariñas MC. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 2011;17: 738-46.
6. Tomizuka T, Takayama Y, Shabayashi T, Fukushima Y, Suzuky Y. Underlying medical conditions and hospitalization for pandemic (H1N1) 2009. Emerg Infect Dis 2010; 16: 1646-7.
7. Jamieson DJ, Honein MA; Rasmussen SA, Williams JL, Swerdlow DL, Bieggerstaff MS. H1N1 2009 Influenza virus Infection during pregnancy in the USA. Lancet 2009; 347:451-8.
8. Zarychansky R, et al. Correlates of severe disease in patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-44.
9. Kato Y. Pneumonia and acute respiratory distress syndrome due to pandemic influenza H1N1 2009. Nippon Rinsho 2010; 68:1666-70.
10. Tutuncu EE, Oztukrk B, Gurbuz Y, Haykir A, Sencan I, Kuscu F. Clinical characteristics of 74 pandemic H1N1 influenza patients from Turkey. Risk factors for fatality. Saudi Med J 2010; 31: 993-8.
11. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010; 65: 645-51.
12. Bai L, Gu L, Cao B, Zhai XL, Lu M, Lu Y. Clinical Features of Pneumonia Caused by Influenza A (H1N1) Virus in Beijing, China. 2011; 139: 1156-64.
13. Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. 2010; 60: 257-63.
14. Díaz E, Rodriguez A, Martin-Loeches I, Lorente L, del Mar Martín M, Pozo JC. Impact of obesity in patients infected with new influenza A (H1N1). 2010; 139: 382-6.
15. Huttunen R, Syrjänen J. Obesity and the outcome of infection. Lancet Infect Dis 2010; 10: 442-3.
16. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. 2009 Jul 17; 58: 749-52.
17. Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. 2010 Sep 28; 28;341:c4779. doi: 10.1136/bmj.c4779.
18. Zepeda-Lopez HM, Perea-Araujo, Miliar-García A, Domínguez- López A, Xoconostle-Cázarez B, Lara-Padilla E. Inside the Outbreak of the 2009 Influenza A (H1N1)v Virus in Mexico. 2010; 5: e13256.
19. Fajardo-Dolci G, Gutierrez-Vega R, Arboleyo-Casanova H, Villalobos A, Wilson KS, García SG. Clinical characteristics of fatalities due to influenza A (H1N1) virus in Mexico, 2010; 5: 505-9.
20. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009.MMWR Morb Mortal Wkly Rep 2009; 58:1071-4.
21. Gordon CL, Johnson PD, Permezel M, Holmes NE; Gutteridge G, McDonald CF. Association between severe pandemic 2009 influenza H1N1 virus infection and inmunoglobulin G2 subclass defiency. Crit Care 2010; 14: R167.
22. Hovden AO, Cox RJ, Haaheim LR. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. Scand J Immunol 2005; 62:36-44.
23. Bermejo-Martín JF, Martín-Loeches I, rello J, Antón A, Almansa R, Xu L. Crit Care 2010; 14: R167.